Quality Chemical Industries Limited (UGSE:QCIL)

Uganda flag Uganda · Delayed Price · Currency is UGX
105.00
0.00 (0.00%)
At close: Aug 1, 2025
Market Cap383.45B
Revenue (ttm)267.13B
Net Income (ttm)40.65B
Shares Out3.65B
EPS (ttm)11.13
PE Ratio9.43
Forward PEn/a
Dividend13.50 (12.86%)
Ex-Dividend DateAug 5, 2025
Volumen/a
Average Volume10,445
Openn/a
Previous Close105.00
Day's Rangen/a
52-Week Range48.92 - 105.00
Beta-0.16
RSI100.00
Earnings DateAug 8, 2025

About UGSE:QCIL

Quality Chemical Industries Limited manufactures and sells pharmaceutical drugs in Uganda. The company offers lamivudine/tenofovir disoproxil fumarate, dolutegravir, efavirenz, and zidovudine tablets for the treatment of HIV infection. It also provides lumartem/lumet tablets for the treatment of malaria; texavir and zentair for the treatment of Hepatitis B; and isoniazid/pyridoxine hydrochloride /sulfamethoxazole trimethoprim tablets for the treatment of tuberculosis. In addition, the company offers emeset for the treatment of nausea and vomiti... [Read more]

Industry Pharmaceutical Preparations
Founded 2005
Employees 362
Stock Exchange Uganda Securities Exchange
Ticker Symbol QCIL
Full Company Profile

Financial Performance

In 2024, UGSE:QCIL's revenue was 267.13 billion, an increase of 0.67% compared to the previous year's 265.34 billion. Earnings were 40.65 billion, an increase of 28.00%.

Financial Statements

News

There is no news available yet.